Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ex-FDA commissioner joins Panacea board

Executive Summary

Former FDA Commissioner Frank Young, MD, is named to Rockville, Md.-based Panacea's board of directors. Young was FDA commissioner from 1984 to 1989. The functional genomics and proteomics firm Panacea, formed in April 1999, has 15 employees. The company expects to begin clinical trials with its lead drug candidate PAN-355 for glioblastoma multiforme by the end of the year...

You may also be interested in...



Coronavirus Update: US Public Confidence In COVID-19 Vaccines Declines

Confidence in the vaccine has slipped in the US, regardless of political affiliation.

Get Real: Orbital’s Chris Bunniss On Real World Evidence’s Potential For OTC Innovation

Can "real world evidence" drive consumer health innovation? HBW Insight speaks to Orbital Research’s Chris Bunniss about RWE’s potential for the OTC industry.

Chiesi Enters Poland’s OTC Market With Smart Pharma Buy

Italy's Chiesi is looking to take a slice of Poland's consumer healthcare market by acquiring infant supplements specialist Smart Pharma.

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel